Niki BioSolutions, Inc. Unrealized Gain (Loss) on Investments
Niki BioSolutions, Inc. (NIKI) reported Unrealized Gain (Loss) on Investments of $6.43 million for the 12-month period ending 2023-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-05-11
| Period end | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|
| 2023-12-31 | $6.43M S-4/A · filed 2026-05-11 | $6.35M 20-F · filed 2024-04-30 |
| 2022-12-31 | -$134.13K 6-K · filed 2025-10-08 | $5.59M 20-F · filed 2024-04-30 |